Pennant Investors’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-35,100
Closed -$455K 26
2024
Q2
$455K Hold
35,100
0.12% 23
2024
Q1
$613K Hold
35,100
0.15% 18
2023
Q4
$330K Buy
+35,100
New +$330K 0.07% 32